<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Komatsu DE</submitter><funding>NIAMS NIH HHS</funding><pagination>366-74</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC2268762</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(3)</volume><pubmed_abstract>&lt;h4>Unlabelled&lt;/h4>HIF-1alpha activates genes under hypoxia and was hypothesized to regulate bone regeneration. Surprisingly, HIF-1alpha+/- fracture calluses are larger, stronger, and stiffer than HIF-1alpha+/+ calluses because of decreased apoptosis. These data identify apoptosis inhibition as a means to enhance bone regeneration.&lt;h4>Introduction&lt;/h4>Bone regeneration subsequent to fracture involves the synergistic activation of multiple signaling pathways. Localized hypoxia after fracture activates hypoxia-inducible factor 1alpha (HIF-1alpha), leading to increased expression of HIF-1 target genes. We therefore hypothesized that HIF-1alpha is a key regulator of bone regeneration.&lt;h4>Materials and methods&lt;/h4>Fixed femoral fractures were generated in mice with partial HIF-1alpha deficiency (HIF-1alpha+/-) and wildtype littermates (HIF-1alpha+/+). Fracture calluses and intact contralateral femurs from postfracture days (PFDs) 21 and 28 (N=5-10) were subjected to microCT evaluation and four-point bending to assess morphometric and mechanical properties. Molecular analyses were carried out on PFD 7, 10, and 14 samples (N=3) to determine differential gene expression at both mRNA and protein levels. Finally, TUNEL staining was performed on PFD 14 samples (N=2) to elucidate differential apoptosis.&lt;h4>Results&lt;/h4>Surprisingly, fracture calluses from HIF-1alpha+/- mice exhibited greater mineralization and were larger, stronger, and stiffer. Microarray analyses focused on hypoxia-induced genes revealed differential expression (between genotypes) of several genes associated with the apoptotic pathway. Real-time PCR confirmed these results, showing higher expression of proapoptotic protein phosphatase 2a (PP2A) and lower expression of anti-apoptotic B-cell leukemia/lymphoma 2 (BCL2) in HIF-1alpha+/+ calluses. Subsequent TUNEL staining showed that HIF-1alpha+/+ calluses contained larger numbers of TUNEL+ chondrocytes and osteoblasts than HIF-1alpha+/- calluses.&lt;h4>Conclusions&lt;/h4>We conclude that partial HIF-1alpha deficiency results in decreased chondrocytic and osteoblastic apoptosis, thereby allowing the development of larger, stiffer calluses and enhancing bone regeneration. Furthermore, apoptosis inhibition may be a promising target for developing new treatments to accelerate bone regeneration.</pubmed_abstract><journal>Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research</journal><pubmed_title>Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiency.</pubmed_title><pmcid>PMC2268762</pmcid><funding_grant_id>R03 AR047603-03</funding_grant_id><funding_grant_id>R03 AR047603-02</funding_grant_id><funding_grant_id>R03AR476032</funding_grant_id><funding_grant_id>R03 AR047603-01</funding_grant_id><pubmed_authors>Bosch-Marce M</pubmed_authors><pubmed_authors>Semenza GL</pubmed_authors><pubmed_authors>Komatsu DE</pubmed_authors><pubmed_authors>Hadjiargyrou M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiency.</name><description>&lt;h4>Unlabelled&lt;/h4>HIF-1alpha activates genes under hypoxia and was hypothesized to regulate bone regeneration. Surprisingly, HIF-1alpha+/- fracture calluses are larger, stronger, and stiffer than HIF-1alpha+/+ calluses because of decreased apoptosis. These data identify apoptosis inhibition as a means to enhance bone regeneration.&lt;h4>Introduction&lt;/h4>Bone regeneration subsequent to fracture involves the synergistic activation of multiple signaling pathways. Localized hypoxia after fracture activates hypoxia-inducible factor 1alpha (HIF-1alpha), leading to increased expression of HIF-1 target genes. We therefore hypothesized that HIF-1alpha is a key regulator of bone regeneration.&lt;h4>Materials and methods&lt;/h4>Fixed femoral fractures were generated in mice with partial HIF-1alpha deficiency (HIF-1alpha+/-) and wildtype littermates (HIF-1alpha+/+). Fracture calluses and intact contralateral femurs from postfracture days (PFDs) 21 and 28 (N=5-10) were subjected to microCT evaluation and four-point bending to assess morphometric and mechanical properties. Molecular analyses were carried out on PFD 7, 10, and 14 samples (N=3) to determine differential gene expression at both mRNA and protein levels. Finally, TUNEL staining was performed on PFD 14 samples (N=2) to elucidate differential apoptosis.&lt;h4>Results&lt;/h4>Surprisingly, fracture calluses from HIF-1alpha+/- mice exhibited greater mineralization and were larger, stronger, and stiffer. Microarray analyses focused on hypoxia-induced genes revealed differential expression (between genotypes) of several genes associated with the apoptotic pathway. Real-time PCR confirmed these results, showing higher expression of proapoptotic protein phosphatase 2a (PP2A) and lower expression of anti-apoptotic B-cell leukemia/lymphoma 2 (BCL2) in HIF-1alpha+/+ calluses. Subsequent TUNEL staining showed that HIF-1alpha+/+ calluses contained larger numbers of TUNEL+ chondrocytes and osteoblasts than HIF-1alpha+/- calluses.&lt;h4>Conclusions&lt;/h4>We conclude that partial HIF-1alpha deficiency results in decreased chondrocytic and osteoblastic apoptosis, thereby allowing the development of larger, stiffer calluses and enhancing bone regeneration. Furthermore, apoptosis inhibition may be a promising target for developing new treatments to accelerate bone regeneration.</description><dates><release>2007-01-01T00:00:00Z</release><publication>2007 Mar</publication><modification>2024-11-10T01:05:15.101Z</modification><creation>2019-06-06T17:29:07Z</creation></dates><accession>S-EPMC2268762</accession><cross_references><pubmed>17181398</pubmed><doi>10.1359/jbmr.061207</doi></cross_references></HashMap>